Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults

Daniel S. Budnitz, Nadine Shehab, Scott R. Kegler et al. · Annals of Internal Medicine · 2007 · 607 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +15

Use of the CHA ₂ DS ₂ -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation

Deirdre A. Lane, Gregory Y.H. Lip · Circulation · 2012 · 387 citations

Medicine, Cardiology, Pharmacology +14

Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry

Sean D. Pokorney, DaJuanicia N. Simon, Laine Thomas et al. · American Heart Journal · 2015 · 238 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)

Adam J. Rose, Elaine M. Hylek, Al Ozonoff et al. · Journal of Thrombosis and Haemostasis · 2010 · 228 citations · Full text

Medicine, Pharmacotherapy, Patient Safety +12